Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 16, 2004
In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study
G von Minckwitz, J-U Blohmer, G Raab, et al.
Hepato-Gastroenterology
|
April 11, 2007
Octreotide for esophageal variceal bleeding treated with endoscopic sclerotherapy: a randomized, placebo-controlled trial
G F Morales, J C Pereira Lima, A P Hornos, et al.
Zentralblatt Fur Gynakologie
|
September 17, 2002
[Evidence-based recommendations on primary treatment of carcinomas of the breast]
G Von Minckwitz, K Brunnert, S D Costa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2001
Dose-dense doxorubicin, docetaxel, and granulocyte colony-stimulating factor support with or without tamoxifen as preoperative therapy in patients with operable carcinoma of the breast: a randomized, controlled, open phase IIb study
G von Minckwitz, S D Costa, G Raab, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 14, 2010
Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trial
G von Minckwitz, H Eidtmann, S Loibl, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|
March 26, 2025
Prevalence of invasive yeast infections in a COVID-19 intensive care unit in northeastern Brazil
S M F R S Medeiros, S D Costa-Júnior, V P Perez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 12, 2007
Pegfilgrastim +/- ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study
G von Minckwitz, S Kümmel, A du Bois, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 28, 2010
First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: results of the MONICA trial
M Kaufmann, N Maass, S D Costa, et al.
The FEBS Journal
|
November 9, 2023
Occurrence and evolutionary conservation analysis of α-helical cationic amphiphilic segments in the human proteome
Igor S D Costa, Tiago Junot, Fernanda L Silva, et al.
Zentralblatt Fur Gynakologie
|
December 26, 2001
[Preoperative chemotherapy in primary operable breast cancer with a dose-dense combination of doxorubicin and docetaxel (ADoc) - Experience of the GEPARDO-GABG study group]
G von Minckwitz, G Raab, M Schütte, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 16, 2004
In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study
G von Minckwitz, J-U Blohmer, G Raab, et al.
Hepato-Gastroenterology
|
April 11, 2007
Octreotide for esophageal variceal bleeding treated with endoscopic sclerotherapy: a randomized, placebo-controlled trial
G F Morales, J C Pereira Lima, A P Hornos, et al.
Zentralblatt Fur Gynakologie
|
September 17, 2002
[Evidence-based recommendations on primary treatment of carcinomas of the breast]
G Von Minckwitz, K Brunnert, S D Costa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2001
Dose-dense doxorubicin, docetaxel, and granulocyte colony-stimulating factor support with or without tamoxifen as preoperative therapy in patients with operable carcinoma of the breast: a randomized, controlled, open phase IIb study
G von Minckwitz, S D Costa, G Raab, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 14, 2010
Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trial
G von Minckwitz, H Eidtmann, S Loibl, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|
March 26, 2025
Prevalence of invasive yeast infections in a COVID-19 intensive care unit in northeastern Brazil
S M F R S Medeiros, S D Costa-Júnior, V P Perez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 12, 2007
Pegfilgrastim +/- ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study
G von Minckwitz, S Kümmel, A du Bois, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 28, 2010
First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: results of the MONICA trial
M Kaufmann, N Maass, S D Costa, et al.
The FEBS Journal
|
November 9, 2023
Occurrence and evolutionary conservation analysis of α-helical cationic amphiphilic segments in the human proteome
Igor S D Costa, Tiago Junot, Fernanda L Silva, et al.
Zentralblatt Fur Gynakologie
|
December 26, 2001
[Preoperative chemotherapy in primary operable breast cancer with a dose-dense combination of doxorubicin and docetaxel (ADoc) - Experience of the GEPARDO-GABG study group]
G von Minckwitz, G Raab, M Schütte, et al.
Page
of 8